| Date Filed | Type | Description |
| 01/12/2022 |
4
| WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.|
Txns:
| Sold 32,548 shares
@ $18.08, valued at
$588.5k
Sold 52,675 shares
@ $18.18, valued at
$957.6k
|
|
| 01/10/2022 |
4
| WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.|
Txns:
| Sold 13,659 shares
@ $18.01, valued at
$246k
Sold 40,914 shares
@ $18.03, valued at
$737.7k
Sold 20,238 shares
@ $18.02, valued at
$364.7k
|
|
| 01/05/2022 |
4
| WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.|
Txns:
| Sold 6,471 shares
@ $18, valued at
$116.5k
Sold 19,795 shares
@ $18, valued at
$356.3k
Sold 92,020 shares
@ $18.01, valued at
$1.7M
|
|
| 12/29/2021 |
4
| WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.|
Txns:
| Sold 71,187 shares
@ $18.01, valued at
$1.3M
Sold 102,476 shares
@ $18.06, valued at
$1.9M
Sold 103,285 shares
@ $18.05, valued at
$1.9M
|
|
| 12/23/2021 |
4
| WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.|
Txns:
| Sold 63,063 shares
@ $18.01, valued at
$1.1M
Sold 30,303 shares
@ $18.13, valued at
$549.4k
|
|
| 12/21/2021 |
4
| WATSA V PREM ET AL (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.|
Txns:
| Sold 6,770 shares
@ $18.25, valued at
$123.6k
Sold 28,156 shares
@ $18, valued at
$506.8k
Sold 52,007 shares
@ $18.07, valued at
$939.8k
|
|
| 03/25/2021 |
GN
| Aspira Women's Health Reports Fourth Quarter and Full Year 2020 Financial Results |
| 02/17/2021 |
GN
| Aspira Women's Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month |
| 02/12/2021 |
GN
| Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference |
| 02/10/2021 |
GN
| Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX™ Clinical Report |
| 02/04/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
GN
| Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock |
| 01/04/2021 |
GN
| Aspira Women's Health, Inc. to Participate in Virtual Investor Events |
| 11/19/2020 |
GN
| Aspira Women's Health, Inc. Announces a Collaborative Agreement with Baylor Genetics for the Co-Development of an Ovarian Cancer Early-Detection Test |
| 11/10/2020 |
GN
| Aspira Women's Health, Inc. Strengthens Executive Leadership with New Appointments |
| 11/09/2020 |
GN
| Aspira Women's Health Strengthens Board of Directors with the Addition of Dr. Sandra E. Brooks |
| 11/05/2020 |
GN
| Aspira Women's Health, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum |
| 11/04/2020 |
GN
| Aspira Women's Health, Inc. to Report Third Quarter 2020 Financial Results on November 12th |
| 10/09/2020 |
GN
| Aspira Women's Health, Inc. to Present at MicroCap Rodeo Best Ideas Bowl October 13-16 |
| 09/15/2020 |
GN
| Aspira Women's Health, Inc. to Host Key Opinion Leader Call on Ovarian Cancer Diagnostics, Innovation Pipeline, and Rebranding Initiatives |
| 09/08/2020 |
GN
| Aspira Women's Health, Inc. to Present at Cantor Virtual Healthcare Conference |
| 08/14/2020 |
GN
| UPDATE – Aspira Women's Health Reports Second Quarter 2020 Financial Results |
| 07/31/2020 |
GN
| Aspira Women's Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th |
| 07/01/2020 |
GN
| Aspira Women's Health Inc. Announces Equity Financing of Approximately $11 Million |
| 11/27/2019 |
SC 13G/A
| Allied World Assurance Co Holdings, AG reports a 16.7% stake in Crescent Capital BDC, Inc. |
| 11/27/2019 |
4
| Allied World Assurance Co Holdings, GmbH (10% Owner) has filed a Form 4 on Crescent Capital BDC, Inc.|
Txns:
| Bought 97,777 shares
@ $20.006, valued at
$2M
Bought 166,714 shares
@ $20.011, valued at
$3.3M
Bought 104,704 shares
@ $20.043, valued at
$2.1M
Bought 206,837 shares
@ $19.547, valued at
$4M
Bought 179,209 shares
@ $19.681, valued at
$3.5M
Bought 346,404 shares
@ $19.792, valued at
$6.9M
Bought 223,650 shares
@ $19.792, valued at
$4.4M
Bought 25,029 shares
@ $19.403, valued at
$485.6k
|
|
| 02/02/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/08/2017 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/07/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 08/04/2017 |
8-K
| Quarterly results |
| 08/03/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2017 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
|